Skip to Content

Tuberculin Purified Protein Derivate for Intradermal Injection

Last Updated: February 2, 2015
Status: Resolved

Products Affected - Description

There are no products affected.

Reason for the Shortage

  • Sanofi Pasteur states the shortage was due to production delays.
  • Par Sterile Products (formerly JHP) states the shortage was due to increased demand for the product.

Available Products

Aplisol, Par Sterile Products (formerly JHP Pharmaceuticals)
5 tuberculin units/0.1 mL, 1 mL (10 tests), multiple dose vial (NDC 42023-0104-01)

5 tuberculin units/0.1 mL, 5 mL (50 tests), multiple dose vial (NDC 42023-0104-05)
 
Tubersol, Sanofi Pasteur
5 tuberculin units/0.1 mL, 1 mL (10 tests), multiple dose vial (NDC 49281-0752-21)
5 tuberculin units/0.1 mL, 5 mL (50 tests), multiple dose vial (NDC 49281-0752-22)

Estimated Resupply Dates

Aplisol and Tubersol vials are available.

Updated

February 2, 2015; September 10, 2014; August 13, 2014; July 14, 2014; May 12, 2014; March 24, 2014; March 6, 2014; January 23, 2014; October 15, 2013; September 16, 2013; July 29, 2013; June 3, 2013; May 15, 2013; April 12, 2013; April 1, 2013; March 7, 2013; January 24, 2013; December 10 2012; November 14, 2012, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide